Cornelis Alexander Izeboud
Direttore/Membro del Consiglio presso TME PHARMA N.V.
Posizioni attive di Cornelis Alexander Izeboud
Società | Posizione | Inizio | Fine |
---|---|---|---|
TME PHARMA N.V. | Direttore/Membro del Consiglio | 30/06/2020 | - |
Independent Dir/Board Member | 30/06/2020 | - | |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
NOMAD Bioscience GmbH
NOMAD Bioscience GmbH BiotechnologyHealth Technology NOMAD Bioscience GmbH provides research and development services in the field of biomaterials. It holds interests in the biotechnologies, biogas, biofuel, and medicinal products. The company was founded by Yuri Gleba in 2008 and is headquartered in Munich, Germany. | Direttore/Membro del Consiglio | 01/04/2020 | - |
Storia della carriera di Cornelis Alexander Izeboud
Precedenti posizioni note di Cornelis Alexander Izeboud
Società | Posizione | Inizio | Fine |
---|---|---|---|
NIBC Bank NV (Research Firm) | Analyst-Equity | - | 01/07/2020 |
Luciole Medical AG
Luciole Medical AG Packaged SoftwareTechnology Services Luciole Medical AG operates as a Swiss medical technology company developing brain oxygenation monitoring systems. The firm's products include Rheopatch, RheoSens, RheoLity and RheoControl. The company was founded in September 2017 and is headquartered in Zurich, Switzerland. | Direttore/Membro del Consiglio | 14/05/2019 | - |
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Analyst-Equity | - | - |
Formazione di Cornelis Alexander Izeboud
University of Utrecht | Doctorate Degree |
Statistiche
Distribuzione geografica
Paesi Bassi | 5 |
Germania | 3 |
Svizzera | 2 |
Posizioni
Director/Board Member | 4 |
Analyst-Equity | 2 |
Doctorate Degree | 1 |
Settori
Finance | 3 |
Health Technology | 3 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
TME PHARMA N.V. | Health Technology |
Aziende private | 5 |
---|---|
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Finance |
NIBC Bank NV (Research Firm) | Finance |
Luciole Medical AG
Luciole Medical AG Packaged SoftwareTechnology Services Luciole Medical AG operates as a Swiss medical technology company developing brain oxygenation monitoring systems. The firm's products include Rheopatch, RheoSens, RheoLity and RheoControl. The company was founded in September 2017 and is headquartered in Zurich, Switzerland. | Technology Services |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Commercial Services |
NOMAD Bioscience GmbH
NOMAD Bioscience GmbH BiotechnologyHealth Technology NOMAD Bioscience GmbH provides research and development services in the field of biomaterials. It holds interests in the biotechnologies, biogas, biofuel, and medicinal products. The company was founded by Yuri Gleba in 2008 and is headquartered in Munich, Germany. | Health Technology |